MGX - Metagenomi Therapeutics
MGX is a company, not a closed-end fund. We still track it - notices about it are below - but most of this site is about funds.
Is anyone targeting this fund?
Yes - one large investor holds a stake, but it has not asked for changes.
- Brian C. Thomas owns 7.3% as a passive investor. On file since Sept 10, 2026.
What this means for you
One or more large investors own more than 5% of this company but have told the regulator they are not seeking changes. That is common for banks, brokers and index funds that hold shares for their clients.
Nothing is required of you. If an investor changes its mind, it must file a new notice within days, and it will show up here.
What happened, and when
-
Sept 10, 2026
Brian C. Thomas now owns 7.3%, as a passive investor.
Original document →
Details: all notices, events and fund facts
| Date | Investor | Stake | Type of notice |
|---|---|---|---|
| Sept 10, 2026 | Brian C. Thomas | 7.3% | Passive investor |
No announcements from the fund on file. Most funds announce their payout on their own website, not in a filing with the regulator, so a cut or a raise there does not show up here.
- Run by
- not filed yet
- Fund family
- not filed yet
- Exchange
- Nasdaq
See this fund's page at the SEC →
Email me when something new is filed for MGX
Free. One email per notice or announcement, usually within a day. No password. Most funds announce payout changes on their own website, where we do not look.